Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1964 1
2004 1
2007 1
2008 2
2009 3
2010 2
2011 5
2012 7
2013 6
2014 10
2015 6
2016 7
2017 5
2018 12
2019 5
2020 12
2021 14
2022 12
2023 10
2024 10
2025 9
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean botulinum toxin sraynaud (28,762 results)?
Botulinum Toxin for the Treatment of Intractable Raynaud Phenomenon.
Gallegos JE, Inglesby DC, Young ZT, Herrera FA. Gallegos JE, et al. J Hand Surg Am. 2021 Jan;46(1):54-59. doi: 10.1016/j.jhsa.2020.07.009. Epub 2020 Sep 16. J Hand Surg Am. 2021. PMID: 32948347 Review.
Raynaud phenomenon (RP) is a condition causing vasospasm in the fingers and toes of patients that can have a significant negative impact on quality of life. ...This article provides a review and update on the use of botulinum toxin as an effective therapy for …
Raynaud phenomenon (RP) is a condition causing vasospasm in the fingers and toes of patients that can have a significant negative imp …
The Use of Botulinum Toxin in Raynaud Phenomenon: A Comprehensive Literature Review.
Lawson O, Sisti A, Konofaos P. Lawson O, et al. Ann Plast Surg. 2023 Jul 1;91(1):159-186. doi: 10.1097/SAP.0000000000003603. Ann Plast Surg. 2023. PMID: 37450876 Review.
AIM OF THE STUDY: To examine the outcomes, techniques, and complications of botulinum toxin use for the treatment of Raynaud disease. METHODS: The PubMed database was queried using "botulinum toxin" AND "Raynaud phenomenon" as titl …
AIM OF THE STUDY: To examine the outcomes, techniques, and complications of botulinum toxin use for the treatment of Raynau …
Botulinum Toxin for the Treatment of Raynaud's Conditions of the Hand: Clinical Practice Updates and Future Directions.
O'Donohoe P, McDonnell J, Wormald J, Aljohmani L, Cronin K, Durcan L, Kennedy O, Dolan R. O'Donohoe P, et al. Toxins (Basel). 2024 Nov 1;16(11):472. doi: 10.3390/toxins16110472. Toxins (Basel). 2024. PMID: 39591227 Free PMC article. Review.
Raynaud's conditions of the hand, referred to commonly as Raynaud's phenomenon, both primary and secondary, represents a spectrum of disorders affecting the digits, characterised by recurrent episodes of vasospasm that result in a triad of symptoms: pa …
Raynaud's conditions of the hand, referred to commonly as Raynaud's phenomenon, both primary and secondary, repr …
Botulinum toxin in the management of primary and secondary Raynaud's phenomenon.
Ennis D, Ahmad Z, Anderson MA, Johnson SR. Ennis D, et al. Best Pract Res Clin Rheumatol. 2021 Sep;35(3):101684. doi: 10.1016/j.berh.2021.101684. Epub 2021 May 5. Best Pract Res Clin Rheumatol. 2021. PMID: 33965340 Review.
In this article, we review effectiveness/efficacy of botulinum toxin injection in primary and secondary RP. We discuss botulinum toxin formulations, dosage, sites of administration, and adverse effects. The evidence for botulinum toxin in …
In this article, we review effectiveness/efficacy of botulinum toxin injection in primary and secondary RP. We discuss botu …
Botulinum toxin A treatment of Raynaud's phenomenon: a review.
Iorio ML, Masden DL, Higgins JP. Iorio ML, et al. Semin Arthritis Rheum. 2012 Feb;41(4):599-603. doi: 10.1016/j.semarthrit.2011.07.006. Epub 2011 Aug 24. Semin Arthritis Rheum. 2012. PMID: 21868066 Review.
METHODS: An Ovid MEDLINE search from 1950 to September 2010 was performed to identify any reports on the use of Botulinum toxin in the treatment of Raynaud's disease or associated vasoconstrictive disorders. All studies pertaining to "Raynaud …
METHODS: An Ovid MEDLINE search from 1950 to September 2010 was performed to identify any reports on the use of Botulinum toxin …
Botulinum toxin type A in the treatment of Raynaud's phenomenon.
Habib SM, Brenninkmeijer EEA, Vermeer MH, de Vries-Bouwstra JK, Velthuis PJ. Habib SM, et al. Dermatol Ther. 2020 Nov;33(6):e14182. doi: 10.1111/dth.14182. Epub 2020 Sep 10. Dermatol Ther. 2020. PMID: 32794364
Raynaud's phenomenon is a vasospastic disorder clinically characterized by cold or stress-induced discoloration of the skin, pain and ulcers of the fingers or toes. ...In the past several years, several reports have shown the benefits of botulinum toxin …
Raynaud's phenomenon is a vasospastic disorder clinically characterized by cold or stress-induced discoloration of the skin, p …
A systematic review of botulinum toxin as a treatment for Raynaud's disease secondary to scleroderma.
Pang C, Iakovou D, Fraser D, Leurent B, Awad L, Langridge B, Butler P. Pang C, et al. Clin Rheumatol. 2025 Jan;44(1):81-96. doi: 10.1007/s10067-024-07237-3. Epub 2024 Nov 30. Clin Rheumatol. 2025. PMID: 39615000 Free PMC article.
Raynaud's phenomenon (RP) is a vasospastic disorder that affects the small blood vessels in the extremities such as the hands, feet, fingers or toes. It is a debilitating condition that can severely impact the patient's quality of life. Botulinum toxin …
Raynaud's phenomenon (RP) is a vasospastic disorder that affects the small blood vessels in the extremities such as the hands, …
127 results